Highlights•Natural infection with Bordetella pertussis induces mucosal antibodies and T
cells.•IL-17+ T RM cells sustain immunity to B. pertussis in the nose.•Current pertussis …

Despite the success of vaccines in preventing many infectious diseases, effective vaccines
against pathogens with ongoing challenges—such as HIV, malaria, and tuberculosis …

ASCO Guidelines provide recommendations with comprehensive review and analyses of
the relevant literature for each recommendation, following the guideline development …

Background Pertussis can lead to serious disease and even death in infants. Older adults
are more vulnerable to complications as well. In high-income countries, acellular pertussis …

Background Immunogenicity of acellular pertussis (aP) vaccines is conventionally assessed
by measuring antibody responses but antibody concentrations wane quickly after …

Despite the implementation of effective paediatric vaccination programmes, pertussis
remains a global health problem. Disease epidemiology has changed over time, shifting …

Background Although pertussis cases globally have been controlled through the Expanded
Programme on Immunization (EPI), the incidence of pertussis has increased significantly in …

Background Recombinant pertussis vaccines inducing long-lasting immune responses
could help to control the rise in pertussis. We here report on persisting antibody responses 2 …

Background Pertussis is a respiratory disease and still endemic despite high vaccination
coverage. In the Dutch national immunisation programme (NIP) whole cell pertussis (wP) …

Corynebacterium diphtheriae (C. diphtheriae) is a relatively rare pathogen in most Western
countries. While toxin producing strains can cause pharyngeal diphtheria with potentially …